Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3522656019 | Product containing erythromycin ethylsuccinate and sulfafurazole acetyl (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3522659014 | Product containing erythromycin ethylsuccinate and sulfisoxazole acetyl | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3522660016 | Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3695107016 | Erythromycin ethyl succinate and sulfafurazole acetyl product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3695108014 | Erythromycin ethylsuccinate and sulfisoxazole acetyl product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | Is a | Product containing erythromycin (medicinal product) | false | Inferred relationship | Some | ||
| Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | Is a | Product containing sulfafurazole (medicinal product) | false | Inferred relationship | Some | ||
| Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | Has active ingredient | Erythromycin ethylsuccinate (substance) | false | Inferred relationship | Some | ||
| Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | Has active ingredient | Sulfafurazole acetyl | false | Inferred relationship | Some | ||
| Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | Is a | Erythromycin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
| Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | Is a | Product containing erythromycin ethylsuccinate | false | Inferred relationship | Some | ||
| Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | Is a | Product containing sulfafurazole in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | Is a | Medicinal product containing macrolide and acting as antibacterial agent (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | Is a | False | Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
FHIR